ARCA Biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial

ARCA biopharma (NASDAQ: ABIO ) and Duke University's Duke Clinical Research Institute (DCRI), the world's largest academic clinical research organization (ARO), today announced a new agreement under which ARCA and the DCRI